Related Experiment Video
Updated: May 21, 2026
06:29
Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Ventricular mass: a clinical and surgical conundrum
Pankaj Kumar Mishra1, Paul Davison, Suresh Lakshmanan
1Cardiothoracic Surgery Department, Heart and Lung Centre, New Cross Hospital, Wolverhampton, UK. mishrapk_25@yahoo.com
BMJ Case Reports
|June 13, 2012
Summary
A rare cardiac tumour, papillary fibroelastoma, was successfully removed from a patient experiencing transient ischemic attacks. This intervention led to a positive clinical outcome, highlighting effective treatment for cardiac masses.
Area of Science:
- Cardiology
- Oncology
- Neurology
Background:
- Cardiac tumours are exceptionally rare clinical occurrences.
- Patients may present with neurological symptoms due to embolic events from cardiac masses.
Observation:
- A patient with a history of transient ischemic attacks and cerebrovascular accidents was undergoing rehabilitation.
- An incidental finding revealed a large left ventricular mass during the patient's recovery period.
Findings:
- The left ventricular mass was surgically excised with a successful clinical outcome.
- Histopathological analysis confirmed the mass to be a papillary fibroelastoma, a type of cardiac tumour.
Implications:
- This case underscores the importance of investigating neurological events that could originate from cardiac sources.
- Successful surgical resection of cardiac tumours like papillary fibroelastoma can lead to significant clinical improvement.
- Early diagnosis and intervention are crucial for managing patients with cardiac tumours presenting with embolic phenomena.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...